Literature DB >> 10849229

The drug epidemic: effects on newborn infants and health resource consumption at a tertiary perinatal centre.

J J Kelly1, P G Davis, P N Henschke.   

Abstract

OBJECTIVES: Illicit drug taking in Australia, with its attendant social and medical consequences, is increasing and the effects extend to maternity hospitals where infants born to addicted mothers have more health problems in the neonatal period. The aims of this study were to evaluate (1) the patterns of illness of such infants and (2) the burden imposed on the neonatal department of a large tertiary maternity centre.
METHODOLOGY: An audit was conducted of all Chemical Dependency Unit (CDU) mothers and babies delivered at the Royal Women's Hospital, Melbourne, Australia during 1997. Data were compared with those from a concurrent control group of mothers and babies randomly generated from the hospital's obstetric database.
RESULTS: Ninety-six infants born to CDU mothers were compared with a control group of 200 infant/mother pairs. The majority of women in the CDU clinic were treated for narcotic addiction with methadone (90%) but most continued to use heroin during pregnancy (68%). Infants born to CDU mothers were significantly less mature and lighter than control infants. Fifty-three (55%) CDU infants required admission to the Special Care Nursery either because of neonatal abstinence syndrome (n = 29) or other medical reasons (n = 24). The median length of hospital stay was significantly longer in CDU compared with control infants (8 vs 3 days, P < 0.01).
CONCLUSIONS: Infants born to drug dependent mothers have more neonatal problems requiring specialized medical and nursing expertise, compared with control infants. These infants are large consumers of scarce health resources.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849229     DOI: 10.1046/j.1440-1754.2000.00492.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  8 in total

1.  Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns.

Authors:  C O'Brien; R Hunt; H E Jeffery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

2.  Oral morphine weaning for neonatal abstinence syndrome at home compared with in-hospital: an observational cohort study.

Authors:  Lauren E Kelly; David Knoppert; Henry Roukema; Michael J Rieder; Gideon Koren
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

Review 3.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

4.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25

5.  Gestational age at enrollment and continued substance use among pregnant women in drug treatment.

Authors:  Mishka Terplan; Joanne Garrett; Katherine Hartmann
Journal:  J Addict Dis       Date:  2009

6.  A Comparison between APGAR Scores and Birth Weight in Infants of Addicted and Non-Addicted Mothers.

Authors:  Esmat Rahi; Mohammad Reza Baneshi; Ehsan Mirkamandar; Saiedeh Haji Maghsoudi; Azam Rastegari
Journal:  Addict Health       Date:  2011 Winter-Spring

7.  Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.

Authors:  Laura J Faherty; Meredith Matone; Molly Passarella; Scott Lorch
Journal:  Matern Child Health J       Date:  2018-06

8.  Comparing serum lead level in drug abuse pregnant women with non-addicted pregnant mothers referring to Shiraz university hospitals in 2017-2018.

Authors:  Mehrdad Rezaie; Seyedeh Zarrin Abolhassanzadeh; Hourvash Haghighinejad
Journal:  J Family Med Prim Care       Date:  2019-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.